CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603. A total of 29 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $491,000 | -61.9% | 454,355 | +7.5% | 0.18% | -56.8% |
| Q1 2022 | $1,289,000 | -21.6% | 422,598 | 0.0% | 0.43% | -14.1% |
| Q4 2021 | $1,644,000 | -26.2% | 422,598 | 0.0% | 0.50% | -30.1% |
| Q3 2021 | $2,227,000 | -9.8% | 422,598 | +1.4% | 0.71% | +15.6% |
| Q2 2021 | $2,468,000 | – | 416,873 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 458,466 | $1,783,000 | 0.72% |
| Affinity Asset Advisors, LLC | 400,000 | $1,548,000 | 0.56% |
| Sio Capital Management, LLC | 422,598 | $1,644,000 | 0.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 508,322 | $1,977,000 | 0.22% |
| Ikarian Capital, LLC | 99,422 | $385,000 | 0.06% |
| PURA VIDA INVESTMENTS, LLC | 102,324 | $398,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 322,373 | $1,254,000 | 0.01% |
| NEXT Financial Group, Inc | 23,852 | $93,000 | 0.01% |
| Point72 Asset Management, L.P. | 230,000 | $895,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 67,600 | $263,000 | 0.00% |